Prognostic Significance of the Baroreflex Sensitivity Changes After Acute Ischemic Stroke
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00422474|
Recruitment Status : Unknown
Verified July 2008 by Far Eastern Memorial Hospital.
Recruitment status was: Recruiting
First Posted : January 17, 2007
Last Update Posted : July 10, 2008
After acute stroke, baroreflex sensitivity (BRS) is impaired. This impaired acute stage BRS has been reported to be predictive of worsen outcome years after stroke in general. However, it is not very clear if the impaired acute stroke BRS would actually persist months after the acute stage. It is also not clear that such change, if any, would correlate with the functional outcome or prognosis after stroke.
The trial is to investigate the longitudinal time course of BRS after ischemic stroke up to the 6th month post stroke and to see if there is any correlation of the changes in BRS with the functional outcome parameters using NIHSS and mRS scores throughout this period.
|Condition or disease|
|Cerebrovascular Accident Baroreflexes Autonomic Nervous System Diseases|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Noninvasive Study of the Time Course of Baroreflex Sensitivity 6-Month After Acute Ischemic Stroke and the Relation of Its Changes With Post Stroke Prognosis|
|Study Start Date :||January 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00422474
|Contact: Siupak Lee, M.D.||email@example.com|
|Far Eastern Memorial Hospital||Recruiting|
|Panchiao City, Taipei County, Taiwan, 220|
|Contact: Siupak Lee, M.D. firstname.lastname@example.org|
|Principal Investigator: Siupak Lee, M.D.|
|Sub-Investigator: Lung Chan, M.D.|
|Sub-Investigator: Dong-feng Yeih, M.D.|
|Principal Investigator:||Siupak Lee, M.D.||Far Eastern Memorial Hospital|